Human Papillomavirus Screening and Vaccine Readiness Program.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 02 Mar 2011
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Cervical cancer; Human papillomavirus infections
- Focus Therapeutic Use
- 02 Mar 2011 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 23 Mar 2009 New trial record